A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
BackgroundCytokine release triggered by a hyperactive immune response is thought to contribute to severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2)–related respiratory failure. Bruton tyrosine kinase (BTK) is involved in innate immunity, and BTK inhibitors block cytokine release. We as...
Saved in:
Main Authors: | Steven P. Treon, Camille N. Kotton, David J. Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph C. Gathe, Tilly A. Varughese, Christopher F. Barnett, Johnny M. Belenchia, Nina M. Clark, Charles M. Farber, Muhammad Bilal Abid, Gulrayz Ahmed, Christopher J. Patterson, Maria L. Guerrera, Jacob D. Soumerai, Vipheaviny A. Chea, Isabel P. Carulli, Jackson Southard, Shuqiang Li, Catherine J. Wu, Kenneth J. Livak, Eric Holmgren, Pil Kim, Carrie Shi, Holly Lin, Vanitha Ramakrishnan, Ying Ou, Scott Olszewski, Lars Rønn Olsen, Derin B. Keskin, Zachary R. Hunter, Christopher Tankersley, Todd Zimmerman, Binod Dhakal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1369619/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FELSEFE-DİN PROBLEMLERİNİN SEBEPLERİ ÜZERİNE FÂRÂBÎ’NİN MİLLE KAVRAMI AÇISINDAN DÜŞÜNMEK
by: Necmi Derin
Published: (2022-07-01) -
MANTIKTA İÇERİĞİN ÖNEMİ
by: Necmi Derin
Published: (2010-10-01) -
VÂCİB VE MÜMKÜN KAVRAMLARININ KULLANIM FARKLILIĞI
by: Necmi Derin
Published: (2012-07-01) -
BTK inhibitors are a possible emerging therapeutic target for gastric cancer
by: José Darío Portillo-Miño, et al.
Published: (2025-03-01) -
Role of the Btk-PLCγ2 Signaling Pathway in the Bone Destruction of Apical Periodontitis
by: Lina Wang, et al.
Published: (2019-01-01)